2021 Colorectal Cancer Market Growth, Trends up to 2025: Orbis Research

Latest Report Available at Orbis research Colorectal Cancer Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.

Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/389996 .

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that has the ability to invade or spread to other parts of the body. Signs and symptoms for this cancer may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time. The current screening regime for this disease comprises of gFOBT, FIT, flexible Sigmoidoscopy, Colonoscopy and others. Further, the treatment for CRC is limited to surgery, chemotherapy and radiotherapy or adjuvant therapies.

The global CRC market would be driven by factors such as rising geriatric population, better reimbursement policies, growing number of obese people and others. However, the dynamics such as stringent regulatory norms, side effects of therapies and high cost of screening tests or drugs are expected to act as a threat for market’s growth. Rising awareness regarding the incidence of CRC and importance of diagnosis has propelled higher compliance with regular tests. Further, in order to harness the market potential, various companies are involved in developing lesser invasive and easy to use screening methods.

The report “Global Colorectal Cancer Market: Industry Analysis & Outlook (2021-2025)” provides a comprehensive study of global market and also major regional markets. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in-depth. The global market is highly competitive consisting of several large enterprises including Bayer AG, Roche Holding AG, Merck & Co., Inc. and Eli Lilly and Company. The competitive landscape of the respective market, along with the company profiles of leading players are discussed in detail.

Browse Complete Report @  http://www.orbisresearch.com/reports/index/global-colorectal-cancer-market-industry-analysis-and-outlook-2021-2025 .

Some points from TOC:

1. Overview
1.1 Colorectal Cancer
1.2 Signs, Symptoms and Stages
1.3 Diagnosis
1.4 Treatment

2. Global Colorectal Cancer Market
2.1 Global Cancer Diagnostics Market Forecast by Value
2.2 Global CRC Screening Patient Volume Forecast
2.3 Global CRC Screening Patient Volume by Region
2.4 Global CRC Screening Product Market
2.4.1 Global C-Scan Cap Revenue Forecast
2.5 Global CRC Patients on Drugs by Volume
2.6 Global CRC Patients on Drugs by Region
2.7 Global CRC Patients on Drugs by Segments
2.8 Global CRC Drug Market
2.8.1 Global Modufolin Revenue Forecast
2.8.2 Global Modufolin Revenue Forecast by Segments
2.8.3 Global Modufolin Revenue as First Line Drug
2.8.4 Global Modufolin Revenue as Second Line Drug
2.8.5 Global Modufolin Revenue as Third Line Drug

Purchase a copy of Colorectal Cancer Market visit @  http://www.orbisresearch.com/contact/purchase/389996  For more information contact sales@orbisresearch.com  .

3. Regional Market
3.1 The US
3.1.1 The US CRC Screening Patient Volume Forecast
3.1.2 The US CRC Screening Volume by Test Mix
3.1.3 The US C-Scan Cap Revenue Forecast
3.1.4 The US Patients on First Line CRC Drug by Volume
3.1.5 The US Patients on Second Line CRC Drug by Volume
3.1.6 The US Patients on Third Line CRC Drug by Volume
3.2 Europe
3.2.1 Europe CRC Screening Patient Volume Forecast
3.2.2 Europe C-Scan Cap Revenue Forecast
3.2.3 Europe Patients on First Line CRC Drug by Volume
3.2.4 Europe Patients on Second Line CRC Drug by Volume
3.2.5 Europe Patients on Third Line CRC Drug by Volume

4. Market Dynamics
4.1 Growth Drivers
4.1.1 Growing Geriatric Population
4.1.2 Rising Healthcare Expenditure
4.1.3 Growing Global GDP per Capita
4.1.4 Surging Obese Population
4.1.5 Rising Awareness Regarding CRC
4.2 Key Trends & Development
4.2.1 Rising Compliance to CRC Screening
4.2.2 Development of New CRC Drugs
4.3 Challenges
4.3.1 High Cost of Screening and Drugs
4.3.2 Side Effects of Drugs
4.3.3 Stringent Drug Approval Process

5. Competitive Landscape
5.1 Global CRC Market
5.1.1 Revenue and Market Cap. Comparison
5.2 Global CRC Drugs Market
5.1.2 Global CRC Drugs Market by Company Share
5.3 Global CRC Screening Market
5.3.1 DNA based CRC Screening Tests Comparison

6. Company Profiles
6.1 Bayer AG
6.1.1 Business Overview
6.1.2 Financial Overview
6.1.3 Business Strategies
6.2 Roche Holding AG
6.2.1 Business Overview
6.2.2 Financial Overview
6.2.3 Business Strategies
6.3 Merck & Co., Inc.
6.3.1 Business Overview
6.3.2 Financial Overview
6.3.3 Business Strategies
6.4 Eli Lilly and Company
6.4.1 Business Overview
6.4.2 Financial Overview
6.4.3 Business Strategies

For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch